[VYNE] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 140.36%
YoY- 122.73%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 6 167 126 178 2,292 4,086 4,258 -98.72%
PBT -7,748 -9,255 -8,235 -8,694 -12,018 -21,285 -19,924 -46.63%
Tax 13 204 241 -13,364 -448 3,439 1,005 -94.44%
NP -7,761 -9,459 -8,476 4,670 -11,570 -21,285 -19,924 -46.57%
Tax Rate - - - - - - - -
Total Cost 7,767 9,626 8,602 -4,492 13,862 25,371 24,182 -53.00%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -129,350.00 -5,664.07 -6,726.98 2,623.60 -504.80 -520.93 -467.92 4100.32%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -2.60 -2.94 -2.63 1.52 -3.89 -7.36 -6.98 -48.13%
EPS Diluted -2.60 -2.94 -2.63 1.52 -3.89 -7.36 -6.98 -48.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.